Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • Bursa Malaysia’s Strategic Objectives In 2005

    Date 25/01/2005

    Bursa Malaysia today announced its strategic objectives for the year in its bid to enhance liquidity and velocity on the local bourse.

  • The Vilnius Stock Exchange To List Two Corporate Bond Issues For The First Time

    Date 24/01/2005

    For the first time in its history, the Vilnius Stock Exchange (VSE) will admit corporate registered bonds to the VSE Current List.

  • Telecom Italia Mobile SpA IWF Changes In The S&P European Indices

    Date 24/01/2005

    Standard & Poor’s will make the following changes in the S&P Europe 350, S&P Euro Plus, S&P Euro indices effective after the close of trading Tuesday, January 25, 2005: Telecom Italia Mobile SpA (Italy, SEDOL: 4876746, GICS: Telecommunication Services, GICS Code: 50102010), a member of the S&P Europe 350, S&P Euro Plus and S&P Euro indices, Investable Weight Factor will change from 0.4387 to 0.146. This is following the acquisition of ordinary shares by Telecom Italia SPA, which has

  • Stock Exchange Of Thailand Announces SVP-Research And Information Division

    Date 24/01/2005

    The Stock Exchange of Thailand (SET) welcomes Mr. Sethaput Suthiwart-Narueput, Ph. D., as its new senior vice president overseeing the Research and Information Division. This division encompasses the research, public information, and international affairs departments.

  • Standard & Poor’s Announces Change To U.S. Index

    Date 24/01/2005

    Gen-Probe Inc. (NASD:GPRO) will replace First Health Group Corp. (NASD:FHCC) in the S&P MidCap 400 after the close of trading on Friday, January 28. First Health Group is being acquired by S&P MidCap 400 constituent Coventry Health Care Inc. (NYSE:CVH) in a deal expected to close on or about that date, pending final approval. Standard & Poor’s will monitor this transaction, and post any relevant updates on its website: www.standardandpoors.com. Gen-Probe Inc. supplies nucleic acid